Liminal BioSciences LMNL

Quarterly report 2022-Q2
added 08-10-2022

Liminal BioSciences DIO Ratio 2011-2026 | LMNL

Annual DIO Ratio Liminal BioSciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	1.68 K	995	171	1.3 K	738	244	135	166	82.2	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.68 K	82.2	612

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Amarin Corporation plc AMRN	292	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Esperion Therapeutics ESPR	2.46 K	$ 2.85	3.26 %	$ 592 M	USA
	Eton Pharmaceuticals ETON	150	$ 23.45	-1.64 %	$ 631 M	USA
	China SXT Pharmaceuticals SXTC	216	$ 1.32	-5.2 %	$ 1.88 M	China